Page last updated: 2024-11-04

sobuzoxane and Carcinoma, Lewis Lung

sobuzoxane has been researched along with Carcinoma, Lewis Lung in 1 studies

sobuzoxane: used in treatment of leukemia L1210

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research Excerpts

ExcerptRelevanceReference
" In animal experiments, Pro and Raz were active against primary tumor growth (35-50 %) and significantly inhibited pulmonary metastasis of LLC (inhibition > 90 %) at dosage below LD(5)."1.33Medicinal chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines. ( Ding, J; Huang, M; Lu, DY; Xu, B; Xu, CH; Zhu, H, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, DY1
Huang, M1
Xu, CH1
Zhu, H1
Xu, B1
Ding, J1

Other Studies

1 other study available for sobuzoxane and Carcinoma, Lewis Lung

ArticleYear
Medicinal chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2006, Volume: 2, Issue:4

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Su

2006